Scarborough, Canada

James M Dunn

This inventor holds 27 USPTO granted patents and 2 published patent applications, primarily in Nucleic Acid Sequencing. Top assignees: Visible Genetics Inc., Hsc Research and Development Limited, Other. Active years: 1996-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: James M Dunn. Retrieved from https://idiyas.com/inventor/james-m-dunn-x6uv7bma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 27 

% Patents Active = 96.3

Average Co-Inventor Count = 2.7

ph-index = 16

Forward Citations = 962(Granted Patents)


Location History:

  • Scarborough, CA (1996 - 2003)
  • Ontario, CA (2003)

Company Filing History:


Years Active: 1996-2003

Loading Chart...
Areas of Expertise:
Nucleic Acid Sequencing
HIV Mutations
BRCA1 Testing
p53 Diagnostics
Thermal Cycling
Isothermal Sequencing
DNA Mutation Detection
Genetic Screening
Automated Sample Processing
Polymorphic Sequences
Single-Tube Sequencing
Virtual DNA Sequencer
27 patents (USPTO):Explore Patents

Title: The Innovative Contributions of James M Dunn in Genetic Research

Introduction:

James M Dunn, based in Scarborough, Canada, is a renowned inventor, holding an impressive portfolio of 26 patents. His work primarily focuses on advancements in genetic analysis, particularly pertaining to HIV mutations and nucleic acid sequencing. Dunn's contributions have significantly influenced research methodologies and practices in the field of genetics.

Latest Patents:

Among his latest patents, two notable innovations stand out:

1. **Method and Kit for Evaluation of HIV Mutations** - This patent introduces a method for extracting critical information regarding the allelic type of genetic material from HIV-infected samples. By utilizing a second nested set of sequencing primers, the method ensures optimal sequencing potential. The necessary reagents are conveniently packaged as a kit, enabling easier access for researchers.

2. **Method for Sequencing of Nucleic Acid Polymers** - This innovative approach allows for the sequencing of a designated target region within a nucleic acid polymer sample in a single vessel. By combining the DNA sample with a sequencing mixture that includes a thermally stable polymerase and unconventional nucleotides, the method leverages multiple thermal cycles to produce a product mixture that can be rigorously analyzed through electrophoresis.

Career Highlights:

Dunn has demonstrated a steadfast commitment to innovation throughout his career. He has made significant contributions to Visible Genetics Inc. and Hsc Research and Development Limited, where he has played a crucial role in advancing genetic testing technologies. His innovations have not only garnered numerous patents but have also enhanced his reputation as a thought leader in the field of genetic research.

Collaborations:

Throughout his career, Dunn has collaborated with esteemed colleagues, including James Leushner and John K Stevens. These partnerships have allowed for the cross-pollination of ideas and techniques, further propelling advancements in genetic research.

Conclusion:

James M Dunn's relentless pursuit of innovation in genetic methodologies has resulted in substantial contributions to the scientific community. His latest patents reflect his commitment to enhancing the understanding and evaluation of genetic materials, particularly in relation to HIV. As research continues to evolve, Dunn's work remains instrumental in shaping the future of genetic analysis.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…